Onc Now | Episode 14
In this episode of the Onc Now Podcast, host Jonathan Sackier is joined by Stephen Chan, Clinical Professor at the Department of Clinical Oncology of the Chinese University of Hong Kong, to discuss groundbreaking trials in hepatobiliary cancers, the role of diet in chronic liver disease, and the future of liver cancer care.
Spotify | Apple | Amazon Music | Youtube | Download MP3 (22 mins)
Stephen Chan is Clinical Professor at the Department of Clinical Oncology of the Chinese University of Hong Kong and President Elect of the Executive Committee for The International Liver Cancer Association. His research interests are in hepatobiliary-pancreatic and neuroendocrine cancers, and he has played a pivotal role in several impactful clinical trials, including the CARES-310 trial and KEYNOTE-966.
Timestamps:
00:00 – Introduction
02:09 – CARES-310 trial for liver cancer
4:33 – Camrelizumab + rivoceranib versus sorafenib
7:07 – Prevention and early detection of liver cancer
10:30 – Impact of lifestyle and diet on liver disease
12:38 – KEYNOTE-966 trial for biliary tract cancer
14:45 – Alternative strategies for liver cancer treatment
17:14 – Key initiatives of the International Liver Cancer Association
19:26 – Chan’s three wishes for healthcare
